1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 28, 2001
Northfield Laboratories Inc.
-----------------------------
(Exact name of registrant as specified in charter)
Delaware 000-24050 36-3378733
-------- --------- ----------
(State of (Commission (IRS Employer
Organization) File Number) Identification No.)
1560 Sherman Ave, Suite 1000
Evanston, IL 60201
----------------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (847) 864-3500
-----------------
Former name or former address, if changed since last report: Not Applicable
2
ITEM 5. OTHER EVENTS
On August 28, 2001, the Registrant publicly disseminated a press release,
attached as Exhibit 99.1, announcing that the Registrant submitted its Biologics
License Application.
(c) Exhibits.
EX 99.1 Press Release dated August 28, 2001.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
Northfield Laboratories Inc.
By: /s/ Richard DeWoskin
--------------------------
Richard DeWoskin
Chief Executive Officer